Browsing: fullyear

Conditions

Merck upgrades its full-year guidance and expects revenue of up to

By 0

Merck announced its financial results for the second quarter of 2026. The company delivered robust performance and upgraded its full-year guidance. Group net sales increased to € 5.4 billion (Q2 2025: € 5.3 billion), representing organic growth of 4.1% compared with the year-earlier quarter. EBITDA pre grew organically by 9.3% to € 1.6 billion (Q2…